TY - GEN AB - Myelin ensheaths axons and increases their conduction velocities. In the central nervous system (CNS) myelin is produced by oligodendrocytes (OLs) that differentiate from oligodendrocyte progenitor cells (OPCs) throughout life. Demyelination and neurodegeneration are observed in many forms of white matter injury and disease, one of which is multiple sclerosis (MS). OPCs accumulate and fail to differentiate into OLs within MS lesions, inside which there is an increase in the levels of extracellular hyaluronic acid (HA), a linear glycosaminoglycan polymer that can be mega-Daltons in size. HA fragments produced by the enzymatic digestion of high molecular weight HA have been shown to inhibit OPC differentiation and myelin formation. There is debate as to which specific hyaluronidase generates these smaller, inhibitory HA fragments. These studies could lead to the identification of CEMIP as a new therapeutic target to promote functional remyelination in a variety of demyelinated lesions, such as preterm white matter injury and MS. AD - Oregon Health and Science University AD - Oregon Health and Science University AD - Oregon Health and Science University AD - Oregon Health and Science University AD - Oregon Health and Science University AU - Peters, Alec AU - Banine, Fatima AU - Su, Weiping AU - Pham, Peter AU - Sherman, Lawrence DA - 2020 DO - 10.6083/pr76f411b DO - DOI ID - 8324 KW - Hyaluronic Acid KW - Extracellular Matrix KW - Multiple Sclerosis KW - Central Nervous System KW - CEMIP KW - myelination KW - oligodendocytes L1 - https://digitalcollections.ohsu.edu/record/8324/files/ResearchWeek.2020.Peters.Alec.pdf L2 - https://digitalcollections.ohsu.edu/record/8324/files/ResearchWeek.2020.Peters.Alec.pdf L4 - https://digitalcollections.ohsu.edu/record/8324/files/ResearchWeek.2020.Peters.Alec.pdf LK - https://digitalcollections.ohsu.edu/record/8324/files/ResearchWeek.2020.Peters.Alec.pdf N2 - Myelin ensheaths axons and increases their conduction velocities. In the central nervous system (CNS) myelin is produced by oligodendrocytes (OLs) that differentiate from oligodendrocyte progenitor cells (OPCs) throughout life. Demyelination and neurodegeneration are observed in many forms of white matter injury and disease, one of which is multiple sclerosis (MS). OPCs accumulate and fail to differentiate into OLs within MS lesions, inside which there is an increase in the levels of extracellular hyaluronic acid (HA), a linear glycosaminoglycan polymer that can be mega-Daltons in size. HA fragments produced by the enzymatic digestion of high molecular weight HA have been shown to inhibit OPC differentiation and myelin formation. There is debate as to which specific hyaluronidase generates these smaller, inhibitory HA fragments. These studies could lead to the identification of CEMIP as a new therapeutic target to promote functional remyelination in a variety of demyelinated lesions, such as preterm white matter injury and MS. PB - Oregon Health and Science University PY - 2020 T1 - Investigating cell migration inducing and hyaluronan binding protein in central nervous system development and disease TI - Investigating cell migration inducing and hyaluronan binding protein in central nervous system development and disease UR - https://digitalcollections.ohsu.edu/record/8324/files/ResearchWeek.2020.Peters.Alec.pdf Y1 - 2020 ER -